CVS Health Ventures led a $40 million investment in healthcare AI company H1 on May 28, 2026. The deal follows a period of active collaboration between the two organizations. Together, they developed an AI model that significantly improved healthcare provider directory accuracy — helping patients connect with the right providers more efficiently. The investment signals CVS Health’s strategic commitment to AI-driven care access solutions and reinforces H1’s position as a leading data and AI platform serving the healthcare ecosystem.
The Investment and What Prompted It
A Partnership That Preceded the Funding
CVS Health Ventures did not arrive at this investment cold. H1 and CVS Health worked together on initiatives designed to improve how patients find and access healthcare providers. One key output of that collaboration was an AI model that meaningfully improved the accuracy of provider directories — a persistent pain point across the industry. Inaccurate provider directories create friction for patients, generate administrative burden for health plans and erode member trust. Consequently, the real-world results of the partnership gave CVS Health Ventures confidence to commit $40 million to H1’s continued growth.
CVS Health Ventures’ Strategic Rationale
Justin Brock, Partner at CVS Health Ventures, explained the investment in clear terms. CVS Health has a long-standing commitment to improving access to care. This collaboration, he said, represents another step in its mission to develop industry-leading solutions that simplify the healthcare experience. Furthermore, Brock expressed enthusiasm for how H1’s data and AI capabilities can drive efficiency and improve the consumer experience across the broader healthcare ecosystem. That dual focus — efficiency for operators and better experience for consumers — captures exactly what CVS Health Ventures looks for in its portfolio companies.
What H1’s Platform Actually Does
Connecting Organizations to the Right Physicians
H1’s mission is straightforward: connect the world to the right doctor. The company builds and operates an AI-powered platform that helps pharmaceutical companies, health plans, health systems and technology organizations identify and engage healthcare professionals for critical workflows. Those workflows span a wide range — from drug development and medical engagement to care navigation, provider data management and network intelligence. In each case, the core problem H1 solves is the same: finding the right physician, at the right time, for the right purpose.
Agentic AI Powering Critical Workflows
H1 combines its deep healthcare data with agentic AI workflows. These workflows automate and accelerate the physician identification and engagement process across all the sectors it serves. Moreover, the platform integrates behavioral signals and relationship data — not just static physician profiles — enabling more nuanced and accurate matching between organizations and providers. This combination of data depth and AI automation is what sets H1 apart from simple provider directories or basic search tools.
The Doctor Graph: H1’s Core Data Asset
At the center of H1’s platform sits the Doctor Graph — a structured representation of physician identity, expertise, relationships and behavioral signals. This proprietary data asset creates a powerful network effect. As more participants across the healthcare ecosystem engage with the platform, the Doctor Graph grows richer and more accurate. Furthermore, H1 has built this asset on one of the world’s largest and most comprehensive global datasets of healthcare professionals. That scale of data — continuously enriched by real-world usage — is difficult for competitors to replicate. It also forms the foundation of the AI workflows H1 deploys across pharmaceutical, health plan and health system clients.
H1’s Customer Base and Market Position
H1’s existing customer base reflects the depth of trust it has built across healthcare. Currently, 85% of the top 20 pharmaceutical companies rely on H1 as a critical partner. Additionally, nine out of 10 of the top health plans are H1 customers. This penetration across both pharma and payer markets is remarkable for a single platform. It demonstrates that H1’s physician data and AI capabilities address needs that cut across the entire healthcare value chain — from drug development to member care management.
Why H1 Did Not Need to Raise Capital
Profitable and Growing
One of the most notable aspects of this funding round is that H1 did not need to raise money. The company turned cash flow and EBITDA profitable in 2025. Furthermore, H1 is forecasting revenue growth above 40% in 2026 — positioning it to operate above the Rule of 40 benchmark, a key indicator of health for software companies. Ariel Katz, co-founder and CEO of H1, was direct about this. The company was not actively seeking capital. However, a strategic partnership with one of the largest healthcare organizations in the world was too valuable to pass up.
Data as a Defensible Moat
Katz also addressed a broader question facing pre-AI-era software companies — whether data-centric businesses remain investable as AI reshapes the software landscape. His argument is that what AI cannot easily replicate is a company built at its core on proprietary data. Workflow software can be rebuilt quickly. A comprehensive, continuously enriched global dataset of physician identity, expertise and behavioral signals cannot. That data moat is precisely what makes H1 attractive — both to customers and, now, to CVS Health Ventures.
Why This Investment Matters for Healthcare AI
The CVS Health Ventures investment in H1 reflects a broader shift in how major healthcare organizations deploy capital. Rather than building AI capabilities entirely in-house, large payers and health systems increasingly invest in purpose-built AI platforms with deep data assets and proven customer traction. H1 fits that profile precisely. Moreover, the deal demonstrates that profitable, data-driven healthcare AI companies can attract strategic investment even in a market where speculative AI valuations dominate headlines. For the payer industry specifically, the combination of CVS Health’s network and H1’s physician intelligence platform creates real potential to improve care navigation at scale.
